Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging

被引:15
|
作者
Jalilian, Amir R. [1 ]
Rostampour, Nima [2 ]
Rowshanfarzad, Pejman [1 ]
Shafaii, Kamaleddin [1 ]
Kamali-Dehghan, Mohsen [1 ]
Akhlaghi, Mehdi [1 ]
机构
[1] AMIRS, Nucl Med Res Grp, Karaj, Japan
[2] Univ Med Sci Hamadan, Sch Med, Dept Med Phys, Hamadan, Iran
关键词
radiopharmaceuticals; copper-61; Cu-61]ATSM hypoxia; positron emission tomography; fibrosarcoma; imaging; PERFORMANCE; GENERATOR; CANCER; LUNG;
D O I
10.2478/v10007-009-0008-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[Cu-61] diacetyl-bis(N-4-methylthiosemicarbazone) ([Cu-61]ATSM) was prepared using in house-made diacetyl-bis(N-4-methylthiosemicarbazone) (ATSM) ligand and [Cu-61]CuCl2 produced via the Zn-nat(p, x)Cu-61 (180 mu A proton irradiation, 22 MeV, 3.2 h) and purified by a ion chromatography method. [Cu-61]ATSM radiochemical purity was > 98 %, as shown by HPLC and RTLC methods. [Cu-61]ATSM was administered into normal and tumor bearing rodents for up to 210 minutes, followed by biodistribution and co-incidence imaging studies. Significant tumor/non-tumor accumulation was observed either by animal sacrification or imaging. [Cu-61]ATSM is a positron emission tomography (PET) radiotracer for tumor hypoxia imaging.
引用
收藏
页码:45 / 55
页数:11
相关论文
共 50 条
  • [1] PREPARATION AND BIOLOGICAL EVALUATION OF [61CU]BLEOMYCIN COMPLEX AS A POSSIBLE PET RADIOPHARMACEUTICAL FOR FIBROSARCOMA TUMOR IMAGING
    Jalilian, A. R.
    Zandi, H.
    Tavakol, A.
    Rostampour, N.
    Farzad, R. Roshan
    Akhlaghi, M.
    Khoshdel, M.
    Bolourinovin, F.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S126 - S126
  • [2] Biodistribution of [61Cu]-oxinate in fibrosarcoma tumors for pet imaging
    Jalilian, A. R.
    Zolghadri, S.
    Faghihi, R.
    Garousi, J.
    Yousefnia, H.
    Majdabadi, A.
    Bolourinovin, F.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S461 - S462
  • [3] Cu-ATSM: A radiopharmaceutical for the PET imaging of hypoxia
    Vavere, Amy L.
    Lewis, Jason S.
    [J]. DALTON TRANSACTIONS, 2007, (43) : 4893 - 4902
  • [4] RADIOSYNTHESIS AND PRECLINICAL EVALUATION OF [61Cu]-9,10-PHENANTHRENEQUINONE THIOSEMICARBAZONE IN FIBROSARCOMA-BEARING ANIMALS FOR PET IMAGING
    Jalilian, A. R.
    Emami, A.
    Akhlaghi, M.
    Shafaii, K.
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S404 - S404
  • [5] Preparation and biological evaluation of [61Cu]bleomycin complex as a possible PET radiopharmaceutical in normal and fibrosarcoma-bearing animals
    Jalilian, Amir R.
    Zandi, Hassan
    Sardari, Daryoush
    Akhlaghi, Mehdi
    Kamali-Dehghan, Mohsen
    Shafaei, Kamaleddin
    Majdabadi, Abbas
    [J]. NUKLEONIKA, 2009, 54 (02) : 135 - 141
  • [6] Preparation, quality control and biodistribution studies of [61Cu]-oxinate for PET tumor imaging
    Jalilian, Amir R.
    Zolghadri, Samaneh
    Faghihi, Reza
    Yousefnia, Hassan
    Garousi, Javad
    Shafaii, Kamaledin
    Bolourinovin, Fatemeh
    [J]. NUKLEONIKA, 2009, 54 (03) : 175 - 179
  • [7] Radiosynthesis and evaluation of [61Cu]-9,10-phenanthrenequinone thiosemicarbazone in fibrosarcoma-bearing animals for PET imaging
    Jalilian, A. R.
    Emami, A.
    Akhlaghi, M.
    Kamali-dehghan, M.
    Shafaii, K.
    Moradkhani, S.
    [J]. RADIOCHIMICA ACTA, 2010, 98 (03) : 175 - 181
  • [8] Preparation,quality control and biodistribution of [61Cu]-doxorubicin for PET imaging
    JALILIAN Amir Reza
    YOUSEFNIA Hassan
    FAGHIHI Reza
    AKHLAGHI Mehdi
    ZANDI Hassan
    [J]. Nuclear Science and Techniques, 2009, 20 (03) : 157 - 162
  • [9] Nuclear model calculation for cyclotron production of 61Cu as a PET imaging
    Mahdi Sadeghi
    Nadia Zandi
    Mahdi Bakhtiari
    [J]. Journal of Radioanalytical and Nuclear Chemistry, 2012, 292 : 777 - 783
  • [10] Nuclear model calculation for cyclotron production of 61Cu as a PET imaging
    Sadeghi, Mahdi
    Zandi, Nadia
    Bakhtiari, Mahdi
    [J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2012, 292 (02) : 777 - 783